Research Area
Product Type
United States ( Change Country )
Zibotentan (ZD4054) Chemical Structure
Recommended Products
Fingolimod (FTY720)
Fingolimod (FTY720) Gilenia is Src-bcr-Abl Inhibitor & S1P receptor agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)- FTY720-phosphate.
ADL5859 HCl
ADL5859 HCl is an δ-opioid receptor agonist (Ki=0.84 nM, EC50=20 nM).
Doxazosin
Doxazosin is an alpha-1 adrenergic receptor blocker.
Naftopidil Dihydrochloride
Naftopidil Dihydrochloride is an antihypertensive agent.
Alfuzosin hydrochloride(Uroxatral)
Alfuzosin(Uroxatral) is an alpha1 receptor antagonist used to treat benign prostatic hyperplasia (BPH).
Dobutamine hydrochloride
Dobutamine is a sympathomimetic compound used in the treatment of heart failure and cardiogenic shock.
Org 27569
Org 27569 is an allosteric modulator of CB1 cannabinoid receptor.
AM-630
AM-630 is a selective CB2 receptor antagonist that binds to CB1 and CB2 receptors with Ki values of 5.2 μM and 31.2 nM, respectively
AM-1241
AM-1241 is a potent and selective cannabinoid receptor CB2agonist with a Ki of 3.4nM at CB2 and 80 fold selectivity over the related CB1 receptor.
Dapagliflozin
Dapagliflozin(BMS-512148) is a potent sodium-glucose transport proteins inhibitor with IC50 of 1.1 nM and 1.4 μM for SGLT2 and SGLT1, respectively.
Biological Activity
Zibotentan (ZD4054)is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM). It was first evaluated as a potential treatment for pulmonary arterial hypertension in the late 1990s. Subsequently, interest switched to the role of endothelins in cancer, particularly hormone-resistant prostate cancer (HRPC).
In vitro, Zibotentan (ZD4054) has been shown to compete with 125I-ET-1 for binding to the cloned human ETA-receptor with an IC50 value of 21 nM. No binding to the ETB receptor was observed with concentrations of zibotentan in excess of 10 μM.
This agent is capable of inhibiting or reducing the multitude of effects that are evoked by ET-1 activation of the ETA receptor and which promote tumor survival, growth and progression. Zibotentan (ZD4054)treatment produced significant inhibition of tumor growth in ovarian and breast xenografts.[1]
References on Zibotentan (ZD4054)
- [1] Xenobiotica. 2011 Sep;41(9):784-96.
Chemical Information
| Molecular Weight (WM): | 424.43 |
|---|---|
| Formula: | C19H16N6O4S |
| CAS No.: | 186497-07-4 |
| Synonyms: |
N/A
|
| Dissolve in (25°C): | DMSO ≥14mg/mL |
| Water <1mg/mL | |
| Ethanol <1mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
Quality Control & MSDS
Research Area
Notes:
Related Inhibitors
Recommended Screening Libraries
Chemical Library
A collection of 864 bioactive compounds
Inhibitor Library
A collection of 481 inhibitors
Kinase Inhibitor Library
A collection of 194 kinase inhibitors
Tyrosine Kinase Inhibitor Library
A collection of 85 tyrosine kinase inhibitors.
FDA Approved Drug Library
A collection of 426 FDA approved drugs
Natural Product Library
A collection of 139 natural products
Chemotherapeutic Agent Library
A collection of 40 chemotherapeutic agents
Epigenetics Compound library
A unique collection of 17 small molecule modulators
Stem Cell Compound library
A unique collection of 47 small molecule inhibitors
GPCR Compound library
A unique collection of 63 GPCR small molecules
Keywords:buy Zibotentan (ZD4054) | Zibotentan (ZD4054) supplier | purchase Zibotentan (ZD4054) | Zibotentan (ZD4054) cost | Zibotentan (ZD4054) manufacturer | order Zibotentan (ZD4054) | Zibotentan (ZD4054) distributor